MEDICAL CHANNEL ASIA

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

ixekizumab (Taltz) plaque psoriasis

Psoriasis is a common skin disease with a global prevalence of 2-3%, and affects over 40,000 people in Singapore. The chronic inflammatory condition with . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: